How Iran Beat its Drug Dilemma

Despite medicines being excluded from sanctions, the number of foreign drugs being imported into Iran has fallen by 30% in recent years as suppliers became reluctant to deal with the country. Like most goods prices for medicines were hit hard as the Rial declined and inflation hit record highs. Bloomberg found out how the country coped with its drug dilemma. (Video by: Muhammad Darwish)

Full Show: What'd You Miss? (08/11)
53:46 - Guests include: Peter Atwater, Financial Insyghts president, and Travis Briggs, ROBO Global chief executive officer. (Source: Bloomberg)
  • Bloomberg Markets: The Trump Economy 8/9/17
  • Full Show: Bloomberg Daybreak: Americas (08/08)
  • Bloomberg Markets: The Trump Economy 8/7/17